24 July 2020 | News
Cancer patients can seek the expert advice of oncologists in Singapore and the region in real-time, via a new specialist telemedicine platform
Photo Credit: Freepik
Singapore medical start-up Oncoshot is partnering with digital healthcare provider MyDoc, to give cancer patients access to second opinion advice from leading oncologists. MyDoc will direct patients from within its network to Oncoshot’s specialist telemedicine platform, which offers remote medical advice from highly qualified oncologists as well as a clinical trial matching solution.
The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes. Cancer, the second leading cause of mortality worldwide, is rising in prevalence in Singapore. According to the Singapore Cancer Registry, one in four people in Singapore may develop cancer in their lifetime, and the number of people living with cancer will continue to increase.
However, with cancer care advancing at an unprecedented rate globally, cancer patients today can choose from a wellspring of treatment options with the potential to elevate their quality of life. Seeking a second opinion to complement their primary healthcare providers can provide them with reassurance on their diagnosis and expose them to a range of therapies.
“Through this partnership, more cancer patients will be able to tap into medical advice from leading private sector cancer care providers from Singapore and the region, and connect to clinical trials on cancer treatments through telemedicine services,” said Dr Huren Sivaraj, Oncoshot CEO and co-founder, who is a medical oncologist at National Cancer Centre Singapore.
“Oncoshot provides valuable specialist consultations and second opinions. MyDoc will add local medical services in each of the regional countries to provide a supportive ecosystem for cancer patients,” said Dr. Vas Metupalle, Chief Information Officer and Co-founder, MyDoc.
Besides second opinion advice, Oncoshot swiftly connects patients with institutes around the world that are running clinical trials, through Artificial Intelligence technology. The medical start-up, along with partners including the Singapore Clinical Research Institute, is building South-east Asia’s first ecosystem for cancer clinical trials and treatment options.